Publications by authors named "Yu-fei Pan"

Claim this Profile
A
Anlotinib monotherapy in recurrent or metastatic nasopharyngeal carcinoma: a multicenter case-series analysis.
Guan-Jie Qin, Yi-Xin Su, Yong Liang, Bin Zhang, Yu-Fei Pan

Radiol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lidocaine potentiates thermal ablation in cholangiocarcinoma by modulating TRPV6-Driven ca/PI3K/AKT/HSF-1 signaling pathway.
Ping-Ping Chen, Yun-Kai Lin, Ming-Xing Xia, Hui-Bo Feng, Yu-Fei Pan

Cancer Lett· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA polymerase II subunit 5-mediating protein limits TLR4-induced innate immune activation in macrophages by inhibiting IKKβ/NF-κB signaling during sepsis.
Shu-Jie Pang, Tian-Yi Jiang, Nai-Guo Wang, Xiao-Wen Cui, Hui Wang, Yu-Fei Pan

Cell Commun Signal· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking the SIRPα-CD47 axis promotes macrophage phagocytosis of exosomes derived from visceral adipose tissue and improves inflammation and metabolism in mice.
Yun-Kai Lin, Yu-Fei Pan, Tian-Yi Jiang, Yi-Bin Chen, Tai-Yu Shang

J Biomed Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF2BP1 Enhances Neprilysin mRNA Stability to Promote Proliferation, Invasion, and Angiogenesis in Placental Trophoblasts.
ChengLing Fan, HongXia Zhou, YuFei Pan, Dan Lu

Int J Gen Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN status determines therapeutic vulnerability to celastrol in cholangiocarcinoma.
Yu-Fei Pan, Lin Zhong, Min Wang, Tian-Yi Jiang, Yun-Kai Lin

Phytomedicine· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma.
Xin Li, Yu-Fei Pan, Yi-Bin Chen, Qian-Qian Wan, Yun-Kai Lin

Cell Death Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Near-Infrared Fluorescence Imaging of Liver Cancer using Dual-Peptide-Functionalized Albumin Particles.
Wei-Tao Dou, Chen Guo, Ling Zhu, Peng Qiu, Weijuan Kan, Yu-Fei Pan

Chem Biomed Imaging· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCK.
Tian-Yi Jiang, Xiao-Wen Cui, Tian-Mei Zeng, Yu-Fei Pan, Yun-Kai Lin

Sci Transl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN Deficiency Facilitates Exosome Secretion and Metastasis in Cholangiocarcinoma by Impairing TFEB-mediated Lysosome Biogenesis.
Tian-Yi Jiang, Yuan-Yuan Shi, Xiao-Wen Cui, Yu-Fei Pan, Yun-Kai Lin

Gastroenterology· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinoma.
Chun Yang, Xiao-Wen Cui, Zhi-Wen Ding, Tian-Yi Jiang, Xiao-Fan Feng, Yu-Fei Pan, Jian Pan

Cancer Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma.
Tian-Mei Zeng, Yu-Fei Pan, Zhen-Gang Yuan, Dong-Sheng Chen, Yun-Jie Song

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgens drive sexual dimorphism in liver metastasis by promoting hepatic accumulation of neutrophils.
Jiao-Jiao Tang, Yu-Fei Pan, Can Chen, Xiu-Liang Cui, Zi-Jun Yan

Cell Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN deficiency facilitates the therapeutic vulnerability to proteasome inhibitor bortezomib in gallbladder cancer.
Tian-Yi Jiang, Xiao-Fan Feng, Zheng Fang, Xiao-Wen Cui, Yun-Kai Lin, Yu-Fei Pan

Cancer Lett· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma.
Tian-Yi Jiang, Yu-Fei Pan, Zheng-Hua Wan, Yun-Kai Lin, Bin Zhu

Sci Transl Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RPB5-Mediating Protein Promotes Cholangiocarcinoma Tumorigenesis and Drug Resistance by Competing With NRF2 for KEAP1 Binding.
Zheng-Hua Wan, Tian-Yi Jiang, Yuan-Yuan Shi, Yu-Fei Pan, Yun-Kai Lin

Hepatology· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of intensity-modulated radiation therapy alone vs. intensity-modulated radiation therapy combined with chemotherapy in elderly nasopharyngeal carcinoma patients (aged >65 years).
Jing-Lin Mi, Yi-Liang Meng, Hong-Liang Wu, Yi-Lin Cao, Bin Zhang, Yu-Fei Pan

Strahlenther Onkol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancy.
Yun-Kai Lin, Zheng Fang, Tian-Yi Jiang, Zheng-Hua Wan, Yu-Fei Pan

Cancer Lett· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy regimens containing taxanes or fluorouracil in nasopharyngeal carcinoma: Which better?
Jing-Lin Mi, Bin Zhang, Yu-Fei Pan, Yi-Xin Su, Jin-Fang Fan

Oral Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.
Bin Zhang, Ying Hu, Rui-Hua Xiong, Yu-Fei Pan, Qian-Lan Xu

Oncotarget· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorogenic 2D Peptidosheet Unravels CD47 as a Potential Biomarker for Profiling Hepatocellular Carcinoma and Cholangiocarcinoma Tissues.
Yun-Han Ma, Wei-Tao Dou, Yu-Fei Pan, Li-Wei Dong, Ye-Xiong Tan

Adv Mater· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : A matched-pair multicenter analysis of outcomes.
Yi-Yuan Dong, Chun Xiang, Jian-Xun Lu, Yi-Xin Su, Yu-Fei Pan

Strahlenther Onkol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma.
Chun Yang, Ye-Xiong Tan, Guang-Zhen Yang, Jian Zhang, Yu-Fei Pan

J Exp Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma.
Jian Zhang, Tian-Yi Jiang, Bei-Ge Jiang, Chun Yang, Ye-Xiong Tan, Yu-Fei Pan

Oncotarget· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
Shuang-Xi Li, Gu-Sheng Tang, Dong-Xun Zhou, Yu-Fei Pan, Ye-Xiong Tan

Cancer· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis